Canada Pension Plan Investment Board
CNCE

Canada Pension Plan Investment Board’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Canada Pension Plan Investment Board’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14,160
Closed -$171K – 1548
2019
Q1 		$171K Buy
+14,160
New +$209K ﹤0.01% 1236

Other funds holding CNCE

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Canada Pension Plan Investment Board's CNCE Position: Q2 2019 in Review

Canada Pension Plan Investment Board sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q2 2019, closing a stake of 14,160 shares — an estimated $171K sold.

Canada Pension Plan Investment Board first reported a position in CNCE in Q1 2019 and held it in 1 quarter. The position peaked at $171K in Q1 2019. 87 funds tracked by Wall St. Rank hold CNCE as of Q2 2019.

  • Canada Pension Plan Investment Board reported no remaining Concert Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 14,160 Concert Pharmaceuticals, Inc. shares in Q2 2019, an estimated $171K.
  • Canada Pension Plan Investment Board first reported a position in Concert Pharmaceuticals, Inc. in Q1 2019 and held it in 1 quarter.
  • Canada Pension Plan Investment Board's Concert Pharmaceuticals, Inc. position peaked at $171K in Q1 2019.
  • 87 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2019.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2019, filed 12 Aug 2019.